Effect of methimazole treatment of maternal thyrotoxicosis on thyroid function in breast-feeding infants.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 8648549.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In 35 infants of lactating mothers with thyrotoxicosis who were receiving 5 to 20 mg methimazole daily, serum levels of thyroxine, triiodothyronine, thyrotropin were within normal ranges 1 month after the start of breast-feeding. Thyroid function in breast-feeding infants of six lactating mothers receiving methimazole, 20 mg for the first, 10 mg for the second, and 5 mg for an additional 4 months, remained normal. These results suggest the safety of methimazole therapy in lactating mothers.
Medical subject headings
- Antithyroid Agents
- Breast Feeding
- Methimazole
- Pregnancy Complications
- Puerperal Disorders
- Thyroid Function Tests
- Thyrotoxicosis